The German Breast Group’s newsroom
Our newsroom provides you with the latest information about the German Breast Group. This section of the website also includes photographic material and information about our events. In addition, our Annual Scientific Reports, which provide an overview of our research activities, can be downloaded here.
24.05.2022 Ovarian Toxicity Assessment
In a paper in "The Breast" we discuss the barriers to, and facilitators of, ovarian toxicity assessment in breast cancer clinical trials.
22.04.2022 ESMO Breast Cancer Meeting
GBG research at ESMO Breast Cancer Meeting 2022 May 3rd to 5th in Berlin.
05.04.2022 2022 ESMO Breast Cancer Award for Sibylle Loibl
ESMO has announced that the 2022 ESMO Breast Cancer Award is presented to Sibylle Loibl for her exceptional contribution to clinical research in breast cancer.
31.01.2022 January 2022: pCR in the breast and axillary lymph nodes correlates with iDFS – results from GeparOcto trial
We are pleased to inform you that an exploratory analysis of the randomized phase III GrparOcto trial has been published in Cancer
27.01.2022 GBG Annual meeting 2022 - Save the date
We are happy to welcome you to the virtual GBG Annual meeting an March 9th to 11th 2022.
31.12.2021 December 2021: mdm2 gene amplification in luminal breast cancer
A biomarker analysis in luminal breast cancer using a humanized tumor mouse (HTM) model has been published in International Journal of Cancer.
03.12.2021 GBG Research at SABCS 2021
We are happy to present our work at the San Antonio Breast Cancer Symposium , December 7-10
30.11.2021 November 2021: Survival analysis of the randomised phase III GeparOcto trial
The survival analysis of the randomized phase III GeparOcto trial has been published in European Journal of Cancer
31.10.2021 October 2021: Association of RAD51 with HRD and clinical outcomes in untreated TNBC
An analysis evaluating RAD51 test and its association with HRD and clinical outcome in primary TNBC from GeparSixto trial has been published in Annals of Oncology.
30.09.2021 September 2021: iDFS and safety results of the randomized phase III GAIN-2 trial
We are delighted to inform you that our results on the GAIN-2 trial has been published in European Journal of Cancer
06.09.2021 GBG research at ESMO 2021
We are happy to present our work at ESMO 2021, September 16-21th
30.08.2021 August 2021: Utility of the CPS + EG scoring system in TNBC patients treated with neoadjuvant chemotherapy
We are delighted to inform you that our analysis on the utility of the CPS + EG score in triple-negative breast cancer patients has been published in European Journal of Cancer
19.07.2021 July 2021: Clinical and molecular characteristics of HER2-low-positive breast cancer
We are pleased to inform you that a pooled analysis of patients with HER2-low-positive breast cancer has been published in The Lancet Oncology
30.06.2021 June 2021: Chemotherapy-induced ovarian failure in young women with early breast cancer
A prospective analysis on chemotherapy-induced ovarian failure in young women with early breast cancer has been published in European Journal of Cancer
01.06.2021 May 2021: Therapy response and prognosis of patients with low HR-positive, HER2-negative early breast cancer
A pooled analysis on therapy response and prognosis of patients with low HR-positive, HER2-negative early breast cancer has been published in European Journal of Cancer
21.05.2021 GBG research at ASCO Virtual Meeting
We are happy to inform you that results of several research projects from GBG and collaborative groups will be presented at the upcoming ASCO Annual Meeting 2021, which will take place from 4 to 8 June.
13.04.2021 April 2021: First results of the rendomized phase III PenelopeB trial
We are delighted to inform you that the first results of the randomized phase III PenelopeB trial have been published in Journal of Clinical Oncology.
13.04.2021 March 2021: Predicting prognosis of breast cancer patients with brain metastases
An analysis including breast cancer patients with brain metastases from the BMBC registry has been published in Cancers
29.03.2021 ESMO BREAST CANCER 2021 - Virtual Meeting
Registration for the ESMO Breast Cancer Virtual Meeting, taking place 5-8 May 2021 is now open.
